MSN Labs Enters Into Licensing Agreement With Lilly To Launch Baricitinib In India For COVID 19
MSN Labs (MSN) has announced today that they have entered into a royalty free, non-exclusive, voluntary license agreement with Eli Lilly and Company of USA for manufacturing and marketing of…
Share